37.565 USD
+0.2 (+0.55%)
Taking everything into account, HRMY scores 8 out of 10 in our fundamental rating. HRMY was compared to 190 industry peers in the Pharmaceuticals industry. HRMY has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. HRMY is evaluated to be cheap and growing strongly. This does not happen too often! These ratings would make HRMY suitable for value and growth and quality investing!
1. Profitability
1.1 Basic Checks
- HRMY had positive earnings in the past year.
- HRMY had a positive operating cash flow in the past year.
- Of the past 5 years HRMY 4 years were profitable.
- HRMY had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 15.37%, HRMY belongs to the best of the industry, outperforming 95.26% of the companies in the same industry.
- HRMY's Return On Equity of 22.23% is amongst the best of the industry. HRMY outperforms 92.63% of its industry peers.
- HRMY's Return On Invested Capital of 17.20% is amongst the best of the industry. HRMY outperforms 94.74% of its industry peers.
- HRMY had an Average Return On Invested Capital over the past 3 years of 18.27%. This is significantly above the industry average of 12.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 15.37% | ||
| ROE | 22.23% | ||
| ROIC | 17.2% |
ROA(3y)19.12%
ROA(5y)10.08%
ROE(3y)31.57%
ROE(5y)9.53%
ROIC(3y)18.27%
ROIC(5y)15.29%
1.3 Margins
- The Profit Margin of HRMY (22.48%) is better than 91.58% of its industry peers.
- HRMY's Profit Margin has improved in the last couple of years.
- HRMY has a Operating Margin of 27.32%. This is amongst the best in the industry. HRMY outperforms 93.16% of its industry peers.
- HRMY's Operating Margin has declined in the last couple of years.
- HRMY has a better Gross Margin (77.70%) than 83.16% of its industry peers.
- In the last couple of years the Gross Margin of HRMY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.32% | ||
| PM (TTM) | 22.48% | ||
| GM | 77.7% |
OM growth 3Y-2.32%
OM growth 5YN/A
PM growth 3Y21.57%
PM growth 5YN/A
GM growth 3Y-1.56%
GM growth 5Y1.26%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HRMY is creating value.
- Compared to 1 year ago, HRMY has more shares outstanding
- The number of shares outstanding for HRMY has been reduced compared to 5 years ago.
- Compared to 1 year ago, HRMY has an improved debt to assets ratio.
2.2 Solvency
- HRMY has an Altman-Z score of 5.53. This indicates that HRMY is financially healthy and has little risk of bankruptcy at the moment.
- HRMY's Altman-Z score of 5.53 is fine compared to the rest of the industry. HRMY outperforms 75.26% of its industry peers.
- The Debt to FCF ratio of HRMY is 0.57, which is an excellent value as it means it would take HRMY, only 0.57 years of fcf income to pay off all of its debts.
- HRMY has a Debt to FCF ratio of 0.57. This is amongst the best in the industry. HRMY outperforms 96.84% of its industry peers.
- A Debt/Equity ratio of 0.18 indicates that HRMY is not too dependend on debt financing.
- HRMY has a Debt to Equity ratio (0.18) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.57 | ||
| Altman-Z | 5.53 |
ROIC/WACC1.81
WACC9.49%
2.3 Liquidity
- HRMY has a Current Ratio of 3.75. This indicates that HRMY is financially healthy and has no problem in meeting its short term obligations.
- With a Current ratio value of 3.75, HRMY perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
- A Quick Ratio of 3.72 indicates that HRMY has no problem at all paying its short term obligations.
- With a Quick ratio value of 3.72, HRMY perfoms like the industry average, outperforming 58.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.75 | ||
| Quick Ratio | 3.72 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 50.71% over the past year.
- The Earnings Per Share has been growing by 44.61% on average over the past years. This is a very strong growth
- Looking at the last year, HRMY shows a very strong growth in Revenue. The Revenue has grown by 21.13%.
- Measured over the past years, HRMY shows a very strong growth in Revenue. The Revenue has been growing by 160.13% on average per year.
EPS 1Y (TTM)50.71%
EPS 3Y44.61%
EPS 5YN/A
EPS Q2Q%10.13%
Revenue 1Y (TTM)21.13%
Revenue growth 3Y32.77%
Revenue growth 5Y160.13%
Sales Q2Q%28.71%
3.2 Future
- Based on estimates for the next years, HRMY will show a very strong growth in Earnings Per Share. The EPS will grow by 35.10% on average per year.
- The Revenue is expected to grow by 14.79% on average over the next years. This is quite good.
EPS Next Y30.39%
EPS Next 2Y29.73%
EPS Next 3Y25%
EPS Next 5Y35.1%
Revenue Next Year21.02%
Revenue Next 2Y18.62%
Revenue Next 3Y16.71%
Revenue Next 5Y14.79%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 11.81 indicates a reasonable valuation of HRMY.
- 88.95% of the companies in the same industry are more expensive than HRMY, based on the Price/Earnings ratio.
- HRMY is valuated cheaply when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 8.89, the valuation of HRMY can be described as very reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of HRMY indicates a rather cheap valuation: HRMY is cheaper than 90.00% of the companies listed in the same industry.
- HRMY is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.98, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.81 | ||
| Fwd PE | 8.89 |
4.2 Price Multiples
- 94.21% of the companies in the same industry are more expensive than HRMY, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, HRMY is valued cheaply inside the industry as 95.79% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.29 | ||
| EV/EBITDA | 6.5 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- HRMY has an outstanding profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as HRMY's earnings are expected to grow with 25.00% in the coming years.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y29.73%
EPS Next 3Y25%
5. Dividend
5.1 Amount
- HRMY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
HARMONY BIOSCIENCES HOLDINGS / HRMY FAQ
Can you provide the ChartMill fundamental rating for HARMONY BIOSCIENCES HOLDINGS?
ChartMill assigns a fundamental rating of 8 / 10 to HRMY.
What is the valuation status of HARMONY BIOSCIENCES HOLDINGS (HRMY) stock?
ChartMill assigns a valuation rating of 9 / 10 to HARMONY BIOSCIENCES HOLDINGS (HRMY). This can be considered as Undervalued.
Can you provide the profitability details for HARMONY BIOSCIENCES HOLDINGS?
HARMONY BIOSCIENCES HOLDINGS (HRMY) has a profitability rating of 8 / 10.
What are the PE and PB ratios of HARMONY BIOSCIENCES HOLDINGS (HRMY) stock?
The Price/Earnings (PE) ratio for HARMONY BIOSCIENCES HOLDINGS (HRMY) is 11.81 and the Price/Book (PB) ratio is 2.59.
What is the earnings growth outlook for HARMONY BIOSCIENCES HOLDINGS?
The Earnings per Share (EPS) of HARMONY BIOSCIENCES HOLDINGS (HRMY) is expected to grow by 30.39% in the next year.